DexCom (NASDAQ:DXCM – Free Report) had its price objective trimmed by Royal Bank of Canada from $120.00 to $115.00 in a research report report published on Friday morning, Benzinga reports.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback